On-Demand Webinar: CAR-T: Why Not Me?
Overview
Chimeric antigen receptor (CAR)-T cell immunotherapy treatment has transformed the treatment of some cancers in some patients. But do we have an idea of which patient factors determine the success of CAR-T therapies. How universal is the applicability of CAR-T and its variations such as CAR-NK.
This webinar consists of an expert panel, discussing the feasibility of predicting the potential of therapies based on patients’ immunological states. There is exploration of possibilities to adjust CAR-T or other immunotherapies, to accommodate patients.
The webinar panel discuss:
- The applicability of CAR-T and its variations
- What can be done to adjust CAR-T to accommodate patients who don't meet eligibility criteria
- How flow cytometry can assist in the research, development and production of these therapies
Webinar Speakers
Dr Yanping Guo
University College London (UCL) Cancer Institute
Yanping is the Flow Cytometry Translational Technology Platform (TTP) manager at the prestigious UCL Cancer Institute. This institute holds an esteemed international reputation for its leadership in diverse realms of cancer research, encompassing fundamental, translational, and clinical dimensions. The Flow Cytometry lab, equipped with the latest equipment, facilitates cutting-edge research that bridges laboratory discoveries to real-world applications.
Yanping gained her D.Phil degree in Clinical Laboratory Sciences from Oxford, backed by a robust background in immunology, hematology, and molecular biology. Her research interests include applying flow and mass cytometry in stem cell and cancer research.
Dr Sarwish Rafiq
Emory School of Medicine
Sarwish Rafiq, PhD is an Assistant Professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine. She is a translational scientist with expertise in the preclinical development of immune-based therapies for cancer. Specifically, Dr. Rafiq’s research aims to use mechanistic insight of immune effector cell function against cancer cells in the tumor microenvironment to inform the development of novel and effective cellular therapies.
Dr Nina Senutovitch
Sartorius
Nina Senutovitch is a Senior Scientist in Product Development at Sartorius and develops high-throughput tools for cell and protein-based analysis. Prior to joining Sartorius in 2019, Nina developed and implemented fluorescent biosensors in a human liver-on-a-chip as a postdoc at the University of Pittsburgh.
Nina earned a PhD from Carnegie Mellon University in Biological Sciences and holds a bachelor’s degree in biochemistry. Her research interests include microphysiological systems, protein engineering and virology.
